In addition, IDO1 expression has been associated with an immunosuppressive TME, infiltration of tumor-associated macrophages (TAMs) and regulatory T lymphocytes (Tregs), which results in a poor survival rate in glioma patients [21,22,23]. This evidence concerns the gene IDO1 and neoplasm.